Juvenescence Completes Phase 1 Trial of PAI-1 Inhibitor
Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership PAI-1 Inhibitor (MDI-2517) demonstrates good safety and […]
Juvenescence Appoints Eileen Jennings-Brown as CTO and Strengthens UAE Presence in Masdar City’s Life Science Innovation Cluster
Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City Jennings-Brown […]
Eric Verdin, our collaborator in the Buck institute presents data on our compound
We were pleased to attend the Longevity Summit 2025 at the Buck Institute for Research on Aging, a vibrant gathering of leaders […]
Presenting at several conferences in the UAE
Juvenescence has carried positive momentum into 2026 following a series of invigorating conferences in hashtag#AbuDhabi, where our team joined discussions on shaping the future of hashtag#longevity and advancing hashtag#healthspan. At […]
Jim Mellon presenting at UBS Year Ahead conference
At the recent UBS Year Ahead 2026 flagship event, our Co-Founder Jim Mellon joined to discuss how advances in longevity science are […]
We are proud to Sponsor and host The Longevity forum in London
We are proud to sponsor The Longevity Forum in London last week – bringing together leaders in science, policy & innovation to […]
Our Director of IR, Yehudah Nevies, presenting at Singapore Week of Innovation & Technology
An incredible week in Singapore 🇸🇬 – grateful to HSBC Innovation Banking , Christina Lee & Kerri L. for the opportunity to […]
Our CSO, Gill Dines at ARDD Conference
Exciting to see such strong global interest in healthspan science at the Aging Research & Drug Discovery Meeting (ARDD) 2025 conference in […]
Jim on Panel at Abu Dhabi Investment Forum in London
Engineering the Future of Health in Abu Dhabi 🧬 Our Deputy Chairman & Co-founder Jim Mellon spoke at the Abu Dhabi Investment […]
Rosalba presenting data from our core medicine
🧬 This week our Senior Research Scientist Rosalba Perrone , Ph.D presented exciting new data from our CD38 inhibitor program at the […]
Richards interview to Jo Shorthouse
💬 There’s still capital out there – it’s just coming from new directions. Our CEO, Richard Marshall CBE, shares his insights on […]